3% Versus 1% polidocanol foam in sclerotherapy of the great saphenous vein: Randomised double-blind controlled trial with a 2-year follow-up. «Study 3/1»;Mousse de polidocanol à 3 % versus 1 % dans la sclé rothérapie de la grande veine saphène: Essai contrôle randomisé en double aveugle avec un suivi de 2 ans. «Étude 3/1»

Phlebologie - Annales Vasculaires

Volumn 61, Issue 1, 2008, Pages 103-109

  Hamel Desnos, C ^a   Ouvry, P ^b   Desnos, P ^b   Allaert, F A ^c  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b McGill University ^*  (France)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Echosclerotherapy; Polidocanol; Sclerosing foam; Sclerotherapy; Varices

Indexed keywords

EID: 77957368677     PISSN: 00318280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. l. Demagny A. Étude comparative de l'efficacité d'un produit sclérosant sous ses formes liquide ou mousse dans la sclérose écho-guidée des crosses de grandes et petites veines saphènes. Phlébologie 2002;55:133-7.
2. Hamel-Desnos C, Desnos P., Wollmann J. C., Ouvry P., Mako S., Allaert F. A. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5. (Pubitemid 38009913)
3. Yamaki T., Nozaki M., et al. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-22. (Pubitemid 38657962)
4. Rabe E., Otto J., Schliephake D., Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomized controlled multicentre clinical trial. Eur J Vase Endovasc Surg 2007; doi: 10.1016/j ejrs.2007-09-006.
5. Hamel-Desnos C, Allaert F. A., and coll. Étude 3/1. Mousse de polidocanol 3 % versus 1 % dans la grande veine saphène. Premiers résultats. Phlébologie 2005;58:165-73.
6. Hamel-Desnos C, Desnos P. L'échosclérothérapie à la mousse en 2004. Technique de la ponction-injection directe. Phlébologie 2004;57:289-300.
7. Breu F. X., Guggenbichler S. European consensus meeting on foam sclerotherapy, April 4-6, 2003, Tegemsee, Germany. Dermatol Surg 2004;30:709-17.
8. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vase Endovascul Surg 2006;32:577-83.
9. Jia X., Mowatt G., Burr J. M., Cassar K, Cook J., Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94:925-36. (Pubitemid 47236534)
10. Cabrera Garrido J. R. Élargissement des limites de la sclérothérapie: nouveaux produits sclérosants. Phlébologie 1997;50:181-8.
11. Monfreux A. Traitement sclérosant des troncs saphéniens et leurs collatérales de gros calibre par la méthode MUS. Phlébologie 1997;50:351-3.
12. Cavezzi A., Frullini A., Ricci S., Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8. (Pubitemid 35231053)
13. Cabrera J., Cabrera J. Jr, Garcia-Olmedo M. A. Treatment of varicose great saphenous veins with sclerosant in micro-foam form: long term outcomes. Phlebology 2000;15:19-23.
14. Frullini A. Cavezzi A. Échosclérose par mousse de tétradécyl-sulfate de sodium et de polidocanol: deux années d'expérience. Phlébologie 2000;53:431-5.
15. ® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-90. (Pubitemid 44913249)
16. Barett J. M., Allen B., Ockelford A., Goldman M. Microfoam ultrasoundguided sclerotherapy of varicose veins in 100 legs. Dermatol Surg January 2004;30:6-12. (Pubitemid 38174021)
17. Bergan J., Pascarella L., Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg 2006;47:9-18.
18. Bountouroglou D. G, Azzam M., Kakkos S. K. and coll. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomized controlled trial. Eur J Vase Endovasc Surg 2006;31; 93-100. (Pubitemid 43024990)
19. Guex J. J., Allaert F. A., Gillet J. L. and coll. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter. Registry of 12, 173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8.
20. Gillet J. L., Guex J. J., Hamel-Desnos C, Schadeck M., Allaert F. Effets secondaires et complications de l'échosclérothérapie à la mousse des troncs saphènes: résultats préliminaires de l'étude CESMOUS. Phlébologie 2007;60:390-1.
21. Hobbs J. T. Surgery or sclerotherapy for varicose veins: 10-year results of a random trial. In: Tesi M., Dormandy J. A., Superficial and deep venous diseases of the lower limbs, Eds. Panrninerva Medica, Turin, Sept. 1984:243-8.
22. Tessari L. Nouvelle technique d'obtention de la scléro-mousse. Phlébologie 2000;53:129.
23. Ceulen R. P., Bullens-Goessens Y. I. and coll. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1 % versus 3 % polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg 2007;33:276-81. (Pubitemid 46328226)
24. Myers K., Jolley D., Clough A., Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vase Endovasc Surg 2007;33:116-21. (Pubitemid 44872674)
25. Frullini A. Foam sclerotherapy: a review. Phlebolymphobgy 2003;40:125-9. (Pubitemid 36869777)